Neuroscientists at UMass Medical School have discovered a molecular braking mechanism for the brain chemical dopamine that may lead to more effective treatments for some forms of attention deficit hyperactivity disorder (ADHD) and other mental health disorders in which abnormal dopamine function plays a central role